Juvenile rheumatoid arthritis (JRA) is a common disorder of childhood that can be potentially devastating physically and psychologically. Over the last several decades, therapy for JRA has changed little. Therapy for advanced JRA is based on trial and error due to the lack of significant clinical trials for both old and new pharmaceutical agents. The following article is a brief overview of the disease and a review of the different treatment options available today with a look at some of the future developments in JRA research.
Giannini E.H.,Cawkwell G.O..“Drug Treatment in Children with Rheumatoid Arthritis: Past, Present and Future,”.Ped Clin North Amer. 1995;42 (5): 1099-1125
Woo P..“The Cytokine Network in Juvenile Chronic Arthritis,”.Rheum Dis Clin North Am. 1997;23 (3): 491-498
11.
Mason T.,Rabinovich C.E.,Fredrickson D.D..“Breast Feeding and the Development of Juvenile Rheumatoid Arthritis,”.J Rheumatol. 1995;22 (6): 1166-1170
12.
Rosenberg A.M..“Evaluation of Associations Between Breast Feeding and Subsequent Development of Juvenile Rheumatoid Arthritis,”.J Rheumatol. 1996;23:1080-1082
13.
Cassidy J.T.,Langman C.B.,Allern S.H..“Bone Mineral Metabolism in Children and Juvenile Rheumatoid Arthritis,”.Pediatr Clin North Am. 1995;42 (5): 1017-1033
14.
Wolf M.D.,Lichter P.R.,Ragsdale C.G..“Prognostic Factors in the Uveitis of Juvenile Rheumatoid Arthritis,”.Ophthalmol. 1987;94:1242-1248
15.
Ceisler E.J.,Foster C.S..“Juvenile Rheumatoid Arthritis and Uveitis: Minimizing the Blinding Complications,”.Int Ophthalmol Clin. 1996;36 (1): 91-107
16.
Chalom E.C.,Goldsmith D.P.,Koehler M.A..“Prevalence and Outcome of Uveitis in a Regional Cohort of Patients of Juvenile Rheumatoid Arthritis,”.J Rheumatol. 1997;24:2031-2034
17.
“Guidelines for Ophthalmologic Examinations,”.Pediatrics. 1993;92:295-296
18.
Dana M.R.,Merayo-Lloves J.,Schaumberg D.A..“Visual Outcome Prognosticators in Juvenile Rheumatoid Arthritis Associated Uveitis,”.Ophthalmology. 1997;104:236-244
19.
Chylack L.T..“The Ocular Manifestations of Juvenile Rheumatoid Arthritis,”.Arthritis Rheum. 1977;20:217-223
20.
Kanski J.J..“Uveitis in Juvenile Chronic Arthritis: Incidence, Clinical Features and Prognosis,”.Eye. 1988;2:641-645
21.
Brewer E.J.,Giannini E.H.,Person D.A..“Early Experiences with Auranofin in Juvenile Rheumatoid Arthritis,”.Am J Med. 1983;75:152-156
22.
Emery H.M.,Bowyer S.L.,Sisung C.E..“Rehabilitation of the Child with a Rheumatic Disease,”.Pediatr Clin North Am. 1995;42 (5): 1263-1283
23.
Duffy C.M.,Duffy K.N.W..“Health Assessment in the Rheumatic Diseases of Childhood,”.Curr Opin Rheumatol. 1997;9:440-447
24.
Graham T.B.,Lovell D.J..“Outcome in Pediatric Rheumatic Disease,”.Curr Opin Rheumatol. 1997;9:443-439
25.
Hackett J.,Johnson B.,Parkin A.,Southwood T..“Physiotherapy and Occupational Therapy for Juvenile Chronic Arthritis: Custom and Practice in Five Centres in the UK, USA, and Canada,”.Br J Rheumatol. 1996;35:695-699
26.
Baum J..“Aspirin in the Treatment of Juvenile Rheumatoid Arthritis,”.Am J Med. 1983;:10-15
27.
Rose C.D.,Doughty R.A..“Pharmacological Management of Juvenile Rheumatoid Arthritis,”.Drugs. 1992;43 (6): 849-863
28.
Doughty R.A.,Giesecke L.,Athreya B..“Salicylate Therapy in Juvenile Rheumatoid Arthritis: Dose, Serum Level, and Toxicity,”.Am J Dis Child. 1980;134:461-463
29.
Steans A.,Manners P.J.,Robinson I.G..“A Multicentre Long Term Evaluation of the Safety and Efficacy of Ibuprofen Syrup in Children with Juvenile Chronic Arthritis,”.Br J Clin Pract. 1990;44 (5): 172-175
30.
Giannini E.H.,Cassidy J.T.,Brewer E.J..“Comparative Efficacy and Safety of Advanced Drug Therapy in Children with Rheumatoid Arthritis,”.Semin Arthritis Rheum. 1993;23 (1): 34-46
31.
Lovell D.J.,Giannini E.H.,Brewer E.J..“Time Course of Response to Nonsteroidal Antiinflammatory Drugs in Juvenile Rheumatoid Arthritis,”.Arthritis Rheum. 1984;27 (12): 1433-1437
Miller J.J..“Prolonged Use of Intravenous Steroid Pulses in the Rheumatic Diseases of Children,”.Pediatrics. 1980;65 (5): 989-994
35.
Brewer E.J.,Giannini E.H.,Barkley E..“Gold Therapy in the Management of Juvenile Rheumatoid Arthritis,”.Arthritis Rheum. 1980;23 (4): 404-411
36.
Giannini E.H.,Brewer E.J.,Person D.A..“Auranofin in the Treatment of Juvenile Rheumatoid Arthritis,”.J Pediatr. 1983;102 (1): 138-141
37.
Giannini E.H.,Brewer E.J.,Kuzmina N..“Auranofin in the Treatment of Juvenile Rheumatoid Arthritis: Results of the USA-USSR Double Blind, Placebo Controlled Trial,”.Arthritis Rheum. 1990;33 (4): 466-476
38.
Giannini E.H.,Barron K.S.,Spencer C.H..“Auranofin Therapy for Juvenile Rheumatoid Arthritis: Results of the Five Year Open Label Extension Trial,”.J Rheumatol. 1991;18:1240-1242
39.
Prieur A.M.,Piussan C.,Manigne P..“Evaluation of D-Penicillamine in Juvenile Chronic Arthritis: A Double Blind Multicenter Study,”.Arthritis Rheum. 1985;28 (4): 376-382
40.
Brewer E.J.,Giannini E.H.,Kuzmina N..“Penicillamine and Hydroxychloroquine in the Treatment of Severe Juvenile Rheumatoid Arthritis,”.N Eng J Med. 1986;314:1269-1276
41.
Hertzberger-Tencate R.,Cats A..“Toxicity of Sulfasalazine in Systemic Juvenile Chronic Arthritis,”.Clin Exp Rheumatol. 1991;9:85-88
42.
Ansell B.M.,Hall M.A.,Loftus J.K..“A Multicentre Pilot Study of Sulfasalazine in Juvenile Chronic Arthritis,”.Clin Exp Rheumatol. 1991;9:201-203
43.
Harel L.,Wagner-Weiner L.,Poznanski A.K..“Effects of Methotrexate on Radiologic Progression in Juvenile Rheumatoid Arthritis,”.Arthritis Rheum. 1993;36 (10): 1370-1374
44.
Wallace C.A.,Bleyer A.,Sherry D.D..“Toxicity and Serum Levels of Methotrexate in Children with Juvenile Rheumatoid Arthritis,”.Arthritis Rheum. 1989;32 (6): 677-681
Giannini E.H.,Brewer E.J.,Kuzmina N..“Methotrexate in Resistant Juvenile Rheumatoid Arthritis: Results of the U.S.-U.S.S.R. Double Blind Placebo Controlled Trial,”.N Eng J Med. 1992;326:1043-1049
47.
Halle F.,Prieur A.M..“Evaluation of Methotrexate in the Treatment of Juvenile Chronic Arthritis According to the Subtype,”.Clin Exp Rheumatol. 1991;9:297-302
48.
Reiff A.,Shaham B.,Wood B.P..“High Dose Methotrexate in the Treatment of Refractory Juvenile Rheumatoid Arthritis,”.Clin Exp Rheumatol. 1995;13:113-118
49.
Hashkes P.J.,Balistreri W.F.,Bove K.E..“The Long Term Effects of Methotrexate Therapy on the Liver in Patients with Juvenile Rheumatoid Arthritis,”.Arthritis Rheum. 1997;40 (12): 2226-2234
50.
Huang J.L.“Methotrexate in the Treatment of Children with Chronic Arthritis: Long Term Observations of Efficacy and Safety,”.Br J Clin Pract. 1996;50 (6): 311-314
51.
Graham L.D.,Myones B.L.,Rivas-Chacon R.F..“Morbidity Associated with Long Term Methotrexate Therapy in Juvenile Rheumatoid Arthritis,”.J Pediatr. 1992;120:468-473
52.
Rose C.D.,Singsen B.H.,Eichenfield A.H..“Safety and Efficacy of Methotrexate Therapy for Juvenile Rheumatoid Arthritis,”.J Pediatr. 1990;117:653-659
53.
Gottlieb B.S.,Keenan G.F.,Lu T..“Discontinuation of Methotrexate Treatment in Juvenile Rheumatoid Arthritis,”.Pediatrics. 1997;100:994-997
54.
Ravelli A.,Viola S.,Ramenghi B..“Frequency of Relapse after Discontinuation of Methotrexate Therapy for Clinical Remission in Juvenile Rheumatoid Arthritis,”.J Rheumatol. 1995;22:1574-1576
55.
Arava® Package Insert. Kansas City, MO: Hoechst Marion Roussel; 1999:
56.
Reiff A.,Rawlings D.J.,Shaham B..“Preliminary Evidence for Cyclosporin A as an Alternative in the Treatment of Recalcitrant Juvenile Rheumatoid Arthritis and Juvenile Dermatomyositis,”.J Rheumatoid. 1997;24:2436-2443
57.
Savolainen H.A.,Kautiainen H.,Isomake H..“Azathioprine in Patients with Juvenile Chronic Arthritis: A Long-Term Follow-up Study,”.J Rheumatol. 1997;24:2444-2450
58.
Wallace C.A.,Sherry D.D..“Trial of Intravenous Pulse Cyclophosphamide and Methylprednisolone in the Treatment of Severe Systemic Onset Juvenile Rheumatoid Arthritis,”.Arthritis Rheum. 1997;40 (10): 1852-1855
59.
Uziel Y.,Laxer R.M.,Schneider R..“Intravenous Immunogobulin Therapy in Systemic Onset Juvenile Rheumatoid Arthritis: A Follow-up Study,”.J Rheumatol. 1996;23:910-918
60.
De Vita S.,Ferraccioli G.F.,Di Poi E..“High Dose Intravenous Immunoglobulin Therapy for Rheumatic Diseases: Clinical Relevance and Personal Experience,”.Clin Exp Rheumatol. 1996;14 (Supp 1S): 585-592
61.
Giannini E.H.,Lovell D.J.,Silverman E.D..“Intravenous Immunoglobulin in the Treatment of Polyarticular Juvenile Rheumatoid Arthritis: A Phase I/II Study,”.J Rheumatol. 1996;23:919-924
Barnett M.L.,Combitchi D.,Trentham D.E..“A Pilot Trial of Oral Type II Collagen in the Treatment of Juvenile Rheumatoid Arthritis,”.Arthritis Rheum. 1996;39 (4): 623-628
65.
Pernice W.,Schuchmann L.,Dippell J..“Therapy for Systemic Juvenile Rheumatoid Arthritis with γ-Interferon: A Pilot Study of Nine Patients,”.Arthritis Rheum. 1989;32 (5): 643-646
